| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:Raxofelast
CAS:128232-14-4
Purity:99% Package:1mg;5mg;10mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Raxofelast
CAS:128232-14-4
Purity:99.97% Package:1mg/RMB 335;5mg/RMB 810;10mg/RMB 1210
|
Raxofelast manufacturers
- Raxofelast
-
- $48.00
-
2026-07-27
- CAS:128232-14-4
- Purity: 99.97%
- Supply Ability: 10g
|
| | Raxofelast Basic information |
| Product Name: | Raxofelast | | Synonyms: | Raxofelast;IRFI-016;2-(5-acetoxy-4,6,7-trimethyl-2,3-dihydrobenzofuran-2-yl)acetic acid;2-Benzofuranacetic acid, 5-(acetyloxy)-2,3-dihydro-4,6,7-trimethyl- | | CAS: | 128232-14-4 | | MF: | C15H18O5 | | MW: | 278.302 | | EINECS: | | | Product Categories: | | | Mol File: | 128232-14-4.mol |  |
| | Raxofelast Chemical Properties |
| | Raxofelast Usage And Synthesis |
| Uses | Raxofelast (IRFI-016) is an antioxidant agent in various models of ischemia-reperfusion injury. Raxofelast has antiproliferative activity in H2O2-stimulated rat aortic smooth muscle cells. Raxofelast attenuates the activation of mitogen-activating protein kinase (MAPK), ERK kinase 1, 2 (MEK1,2) and protein kinase C (PKC) without affecting Ras expression[1]. | | References | [1] Kyung-Hye Lee, et al. Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells. Eur J Pharmacol. 2004, 484, 2-3. DOI:10.1016/j.ejphar.2003.11.012 |
| | Raxofelast Preparation Products And Raw materials |
|